Sol-Gel Technologies to Host Analyst & Investor Day on July 25, 2019
NESS ZIONA,
The event will include updates regarding our clinical development programs, commercial plans, and plans for advancing new pipeline candidates into clinical studies.
The event will feature presentations by management and leading dermatologists including:
Linda Stein Gold , MD., Director ofDermatology Clinical Research atHenry Ford Health System Jeffrey Sugarman , MD., Ph.D., Medical Director Northern California Medical Associates, Assoc. Clinical Professor,University of California, San Francisco Mori Arkin , Chairman of The Board of DirectorsAlon Seri-Levy , Ph.D., Co-Founder and Chief Executive OfficerJohn Vieira , U.S. Head of Commercialization
For registration and more information on the Analyst & Investor Day, please visit Solgel.troutaccess.com
About
For further information, please contact:
Sol-Gel Contact:
Chief Financial Officer
+972-8-9313433
Investor Contact:
Solebury Trout
+1-617-221-9197
[email protected]
Source: Sol-Gel Technologies Ltd.
Source: Sol-Gel Technologies Ltd.